HPV Self-Test Intervention in Ohio Appalachia

Status Completed

Clinical Trial Summary

This study will pilot test a culturally appropriate human papillomavirus (HPV) self-test intervention among women from Ohio Appalachia in order to determine the feasibility of HPV self-testing as a potential cervical cancer screening strategy. The intervention group will receive culturally appropriate materials and the control group will receive standard materials with their HPV self-test device.

Clinical Trial Description

PRIMARY OBJECTIVES:

I. To determine the feasibility of HPV self-testing as a potential cervical cancer screening strategy and obtain preliminary efficacy data of culturally appropriate materials on self-test use.

OUTLINE:

Participants are randomized to 1 of 2 arms.

ARM I: Participants receive a study kit that includes culturally appropriate instructions for using and returning the HPV self-test device and a photo story information sheet about HPV and HPV self-testing. Participants are asked to complete the HPV self-test and return the test for HPV testing.

ARM II: Participants receive a study kit that includes standard instructions for using and returning the HPV self-test device and a standard information sheet about HPV and cervical cancer. Participants are asked to complete the HPV self-test and return the test for HPV testing.

Participants are followed up at 4 weeks for return of their HPV self-test device and then for 2 months after notification letters are sent. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02460237
Study type	Interventional
Source	Ohio State University Comprehensive Cancer Center
Contact
Status	Completed
Phase	N/A
Start date	November 2015
Completion date	March 15, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05458869` - Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual Trauma
Completed	`NCT01932697` - Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer	Phase 2
Completed	`NCT03265743` - HPV Vaccination in Women With Cystic Fibrosis	N/A
Completed	`NCT00543543` - Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)	Phase 3
Recruiting	`NCT04226313` - Self-sampling for Non-attenders to Cervical Cancer Screening	N/A
Completed	`NCT06199128` - Efficacy and Safety of Carboxymethyl Beta-glucan and Policarbophil in HPV Positive Patients
Active, not recruiting	`NCT01824537` - Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study	Phase 4
Terminated	`NCT01082861` - Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccination	Phase 4
Unknown status	`NCT01087164` - Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers	N/A
Completed	`NCT01265212` - Prevalence of Human Papillomavirus in Men Living in the Northern Plains	N/A
Completed	`NCT00572832` - Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting	N/A
Completed	`NCT03158220` - Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)	Phase 3
Recruiting	`NCT05210348` - Clinical Evaluation of Detection of High Risk HPV in Urine
Completed	`NCT05680454` - A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine	Phase 1
Completed	`NCT04133610` - HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs	N/A
Completed	`NCT00988884` - A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)	Phase 3
Not yet recruiting	`NCT05981807` - HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population
Recruiting	`NCT03302858` - A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand	Phase 2
Completed	`NCT01694875` - Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System	N/A
Completed	`NCT01158209` - An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt	N/A